Infections in minority populations in the United States: An evaluation of pathogenetic risk factors

Infectious Diseases in Clinical Practice

Volumn 6, Issue 4, 1997, Pages 232-238

  Rajagopalan, Shobita ^a,b   Yoshikawa, Thomas T ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b KING DREW MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN S;

COCCIDIOIDOMYCOSIS; ETHNIC GROUP; GENETIC SUSCEPTIBILITY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION; MALARIA FALCIPARUM; MINORITY GROUP; PATHOGENESIS; PREVALENCE; RACE DIFFERENCE; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNITED STATES;

EID: 0030990509     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199705000-00004     Document Type: Short Survey

References (68)

1. CDC. National electronic telecommunications system for surveillance: United States, 1990-1991. MMWR Morb Mortal Wkly Rep 1991;40:502-3.
2. CDC. Reporting of race and ethnicity in the National Notifiable Disease Surveillance. MMWR Morb Mortal Wkly Rep 1992;41:653-7.
3. United States Department of Commerce, Office of Federal Statistical Policy and Standards. Statistical and policy handbook. Washington: GPO, 1991.
4. African-American Studies Department, Pennsylvania State University. Tuberculosis in African-American and minority populations. Soc Acad Minor Phys 1994;5:11-5.
5. Garrod A. The inborn factors in disease. In: Scriver CR, Childs B, editors. Garrod's inborn factors in disease. New York: Oxford, 1989:171.
6. Kallman FJ, Reisner D. Twin studies on the significance of genetic factors in tuberculosis. Am Rev Tubercle 1943;47: 549-74.
7. Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 1978;117:621-4.
8. Hirsch A. Handbook of geographical and historical pathology. diseases of organs and parts Vol. 3. London. New Sydenham Society. 1886.228.
9. Puffer RR. Familial susceptibility to tuberculosis. Cambridge: Harvard University Press, 1944:80
10. Motulsky AG. Metabolic polymorphisms and the role of infectious diseases in human evolution. Hum Biol 1960; 32:28-62.
11. Stead WW, Senner JW, Reddick WT, Lofgren JP. Racial differences and M. tuberculosis infection. N Engl J Med 1990;322:422-7
12. Torchia MM. Tuberculosis among American Negroes: medical research on a racial disease. 1830-1950. J Hist Med 1977;32:252-79.
13. Rich AR. The pathogenesis of tuberculosis. 2nd ed. Springfield: Charles C Thomas, 1951:131-48.
14. Kushigemachi M, Schneiderman LJ, Barrett-Connor E. Racial differences in susceptibility to tuberculosis: risk of disease after infection. J Chron Dis 1984;137:853-62.
15. Lurie MB, Abramson S, Heppeston AG. On the response of genetically resistant and susceptible rabbits to the quantitative inhalation of human type tubercle bacilli and the nature of resistance to tuberculosis. J Exp Med 1952; 95:119-33.
16. Skamene E. Genetic control of susceptibility to mycobacterial infections. Rev Infect Dis 1989;11(2 Suppl):S394-S399.
17. Crowle AJ. The tubercle Bacillus-human macrophage relationship studied in vitro. In: Bendinelli M, Friedman H, editors. Mycobacterium tuberculosis: Interactions with the immune system. New York: Plenum, 1988:99-131.
18. Crowle AJ, Elkins N. Relative permissiveness of macrophages from black and white people for virulent tubercle bacilli. Infect Immunol 1990;58:632-38
19. Crowle AJ, Ross EJ, May MH. Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immunol 1987;55:2945-50.
20. Davies PD. A possible link between vitamin D deficiency and impaired host defense to Mycobacterium tuberculosis. Tubercle 1985;66:301-6.
21. Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J Evidence for alteration of the vitamin-D endocrine system in blacks. J Clin Invest 1985;76:470-3
22. Rook GA. The role of vitamin D in tuberculosis. Am Rev Respir Dis 1988;138.768-70.
23. Rieder HL, Cauthen GM, Kelly GD, et al. Tuberculosis in the United States JAMA 1989;262:385-89.
24. Onorato IM, Kent JH, Castro KG. Epidemiology of tuberculosis. In: Friedman LX, editor. Tuberculosis: a clinical handbook. London: Chapman and Hall, 1994.
25. CDC. Tuberculosis in the United States: 1985-1986. Washington DC: U.S. Government Printing Office, Health and Human Services Publication No. 88-8322. 1987.
26. Cantwell MF, Snider DE Jr, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985-1992. JAMA 1994;272:535-39.
27. CDC. Tuberculosis among foreign-born persons entering the United States. MMWR Morb Mortal Wkly Rep 1990: 39.1-21.
28. Johnson WM. Racial factors in coccidioidomycosis: mortality experience in Arizona. Ariz Med 1982;39:18-24.
29. Johnson WM Coccidioidomycosis mortality in Arizona. In. Ajello L, editor Current clinical and diagnostic status. Miami: Symposia Specialists. 1977:33-4.
30. Kelly PC, Sievers ML, Thompson R, Echols C. Coccidioidal meningitis: results of treatment in 22 patients In: Ajello L, editor. Coccidioidomycosis: current clinical and diagnostic status. Miami: Symposia Specialists, 1977:239-51
31. Pappagianis D, Crane R. Survival in coccidioidal meningitis since introduction of amphotericin B In: Allejo L, editor. Coccidioidomycosis: current clinical and diagnostic status. Miami: Symposia Specialists, 1977:223-37.
32. Sarosi GA, Parker JD, Doto IL, Tosh FE. Chronic pulmonary coccidioidomycosis: a national Communicable Disease Center cooperative mycosis study. N Engl J Med 1970;283:325-29.
33. Bayer AS, Yoshikawa TT, Guze LB. Chronic progressive coccidioidal pneumonitis: report of six cases with clinical, roentgenographic, serologic, and therapeutic features. Arch Intern Med 1979;139:536-40.
34. Pappagianis D, Lindsay S, Beall S, Williams P. Ethnic background and the clinical course of coccidioidomycosis [letter]. Am Rev Respir Dis 1979;120:959-61.
35. Bayer AS, Yoshikawa TT, Galpin JE, Guze LB. Unusual syndromes of coccidioidomycosis: diagnostic and therapeutic considerations. Medicine (Baltimore) 1976;55:131-52.
36. Pappagianis D, Einstein H. Tempest from Tehachapi takes toll or Coccidioides conveyed aloft and far. West J Med 1978;129:527-30.
37. Flynn NM, Hoeprich PD, Kawachi MM, et al. An unusual outbreak of windborne coccidioidomycosis N Engl J Med 1979;301:358-61.
38. Williams PL, Sable DL, Mendez P, Smyth LT. Symptomatic coccidioidomycosis following a severe natural dust storm: an outbreak at the Naval Air Station, Lemore, California. Chest 1979;76:566-70.
39. Johnson WM. Occupational factors in coccidioidomycosis. J Occup Med 1981;23:367-74.
40. Norman IL, Lawler IL. Coccidioidomycosis: review of the literature and report of nine cases. US Naval Med Bull 1949;49:1005-20.
41. Huppert M. Racism in coccidioidomycosis [letter]. Am Rev Respir Dis 1978;118:797-8.
42. Sievers ML Coccidioidomycosis and race [letter]. Am Rev Respir Dis 1979;119:839.
43. Hoeprich PD. Racial susceptibility to coccidioidomycosis [letter]. N Engl J Med 1980;302:59.
44. Drutz D. Racial susceptibility to coccidioidomycosis [letter]. N Engl J Med 1980;302:59.
45. Sievers ML. Racial susceptibility to coccidioidomycosis [letter]. N Engl J Med 1980;302:58-9.
46. Deresinski SC, Stevens DA. Coccidioidomycosis in compromised hosts. Medicine (Baltimore) 1976;54:377-95.
47. Fraser DW, Ward JI, Ajello L, Plikaytis BD. Aspergillosis and other systemic mycoses: the growing problem. JAMA 1979;242:1631-35.
48. Benacerraf B, McDevitt HO. Histocompatibility-linked immune response genes. Science 1972;175:273-78
49. Bach FH, Bach ML The major histocompatibility complex: genetic control of cell-mediated immune reactions. In: Samter M, editor. Immunological disease. 3rd ed. Boston: Little Brown. 1978:325-40.
50. CDC. HIV/AIDS surveillance report: January 1992;2:1-22.
51. CDC. HIV/AIDS surveillance report: 1995;7:1-35.
52. Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of HIV disease. N Engl J Med 1995;333: 751-6.
53. Turner BJ, Markson LE, McKee LJ, Houchens R, Fanning T. Healthcare delivery, zidovudine use, and survival of women and men with AIDS. J Acquir Immune Defic Syndr 1994;7:1250-62.
54. Moran JS, Aral SO, Jenkins WC, Peterman TA, Alexander ER. The impact of STDs on minority populations. Public Health Rep 1989;104:560-5.
55. Turner BJ, Markson LE, McKee LJ, Houchens R, Fanning T. Health care delivery, zidovudine use, and survival of women and men with AIDS. J Acquir Immune Defic Syndr 1994;7:1250-62.
56. Division of STD Prevention. Sexually transmitted disease surveillance report, 1994. U.S. Department of Health and Human Services, Public Health Service, Atlanta: CDC, September 1995.
57. Tooney KE, Moran JS, Rafferty MP, Beckett GA. Epidemiological considerations of STDs in underserved populations. Infect Dis Clin North Am 1993;7:739-52.
58. Martin DH, DiCarlo RP. Epidemiologic changes in genital ulcer disease in the US: the crack cocaine connection. Sex Transm Dis 1994;21(2 Suppl):S76-S80.
59. Schwarcz SK, Bolan GA, Fullilove M, et al. Crack cocaine and gonorrhea among black adolescents. Sex Transm Dis 1992;19:7-13.
60. Luzzatto L. Red cell genetics-malaria susceptibility. Blood 1979;54:961-76.
61. Luzzatto L, Nwachuker-Jarrett RS, Reddy S. Increased sickling of parasitized erythrocytes as mechanism of resistance against malaria in sickle-cell trait. Lancet 1970; 642:319-21.
62. Roth EF, Friedman M, Ueda Y, Tellez I, Trager W, Nagel RL. Sickling rates of human AS red cells infected in vitro with Plasmodium falciparum malaria. Science 1978;202: 650-2.
63. Friedman MJ, Roth EF, Nagel RL, Trager W. P falciparum: physiological interactions between the malaria parasite and the sickle cell. Exp Parasitol 1979;47:73-80.
64. Friedman M. Erythrocyte mechanism of sickle cell resistance to malaria. Proc Natl Acad Sci U S A 1978;75: 1994-7.
65. Pasvol G, Weatherall DJ, Wilson RJM. Cellular mechanisms for the protective effect of hemoglobin S against P. falciparum malaria. Nature 1978;274:701-3
66. Markell MK, Voge M, John DT. Medical parasitology: malaria. Philadelphia: Saunders. 1992:112-4.
67. Miller LH, McGinniss MH, Holland DV, Sigmon P. The Duffy blood group phenotype in American blacks infected with Plasmodium vivax in Vietnam. Am J Trop Med Hyg 1978;27:1069-72.
68. Yoshikawa TT, Norman DC. Aging and clinical practice: infectious disease - diagnosis and treatment. New York: Igaku-Shoin, 1987:3-19.